Insight Advisors, LLC Mereo Biopharma Group PLC Transaction History

Insight Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.04 - $1.7 $16,340 - $26,710	-15,712 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$1.51 - $2.59 $29,540 - $50,668	-19,563 Reduced 55.46%	15,712 $25,000
Q3 2021 Nov 12, 2021	SELL	$2.2 - $3.17 $287,210 - $413,843	-130,550 Reduced 78.73%	35,275 $84,000
Q2 2021 Aug 12, 2021	SELL	$2.94 - $4.08 $184,926 - $256,632	-62,900 Reduced 27.5%	165,825 $438,000
Q1 2021 May 17, 2021	BUY	$2.6 - $4.43 $594,685 - $1.01 Million	228,725 New	228,725 $812,000

107M

209K

479K

Ticker MREO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,986,000
Market Cap $419M
Description
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...

Get notified when there are updates to the investment portfolio of Insight Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Insight Advisors, LLC with notifications on news.